Correlation Between Accenture Plc and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Accenture Plc and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accenture Plc and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Accenture plc and Novavax, you can compare the effects of market volatilities on Accenture Plc and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accenture Plc with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accenture Plc and Novavax.

Diversification Opportunities for Accenture Plc and Novavax

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Accenture and Novavax is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Accenture plc and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Accenture Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accenture plc are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Accenture Plc i.e., Accenture Plc and Novavax go up and down completely randomly.

Pair Corralation between Accenture Plc and Novavax

Assuming the 90 days horizon Accenture plc is expected to generate 0.46 times more return on investment than Novavax. However, Accenture plc is 2.18 times less risky than Novavax. It trades about 0.09 of its potential returns per unit of risk. Novavax is currently generating about -0.1 per unit of risk. If you would invest  33,305  in Accenture plc on August 29, 2024 and sell it today you would earn a total of  1,145  from holding Accenture plc or generate 3.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Accenture plc  vs.  Novavax

 Performance 
       Timeline  
Accenture plc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Accenture plc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Accenture Plc may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Novavax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novavax has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Accenture Plc and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Accenture Plc and Novavax

The main advantage of trading using opposite Accenture Plc and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accenture Plc position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind Accenture plc and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas